NEW Webinar: Genetics and Kidney Health | What Nephrologists Should Know Join our upcoming webinar about the latest guidelines from the National Kidney Foundation (NKF) and the Kidney Disease: Improving Global Outcomes (KDIGO) organization regarding the importance of genetic testing for patients with CKD. During this webinar, we will discuss: 🧬Newest recommendations from NKF, KDIGO, and NEJM on genetic testing for CKD 🧬Clinical utility of genetic testing 🧬How Dr. Rastogi has integrated genetic testing into this clinical practice 🧬Real-world case studies demonstrating the value of Renasight Register today: https://ow.ly/bwvk50TExrf
Natera Organ Health
Biotechnology Research
Austin, TX 2,969 followers
Improving patient outcomes through an innovative platform for genetic testing in kidney health and organ transplantation
About us
Improving patient outcomes through an innovative platform for genetic testing in kidney health and organ transplantation. Follow us on Twitter: @NateraNeph
- Website
-
https://www.natera.com/organ-health
External link for Natera Organ Health
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Austin, TX
- Founded
- 2004
- Specialties
- transplant, kidney transplant, transplant rejection, cell-free DNA, and genetic testing
Updates
-
There is still time to register! 📊 🩺How to engage your kidney transplant recipients: Being proactive with Prospera™ on their transplant care Hear our Natera clinical nurse coordinator discuss effective strategies to engage kidney transplant recipients in proactive discussions about their post-transplant care. We'll explore the benefits of using the Prospera™ test for ongoing surveillance, ensuring patients understand the importance of early detection and intervention. Enhance your communication skills, empower your patients, and optimize long-term transplant outcomes! 📅Friday, October 4th, 2024 🕒12:00 PM ET | 9:00 AM PT REGISTER HERE: https://ow.ly/QjfX50TCrFr #Transplant #Natera #Kidney #KidneyCare #PostTransplant
-
📊🧬The recently published SLAM study establishes Prospera Lung as an accurate, noninvasive transplant assessment for Single Lung Transplantation. SLAM is the largest study of commercial dd-cfDNA tests in single lung transplant. Click below to learn more. https://ow.ly/uQXM50TCrim #LungTransplant #Natera
-
Join our upcoming webinar 📊 🩺How to engage your kidney transplant recipients: Being proactive with Prospera™ on their transplant care Hear our Natera clinical nurse coordinator discuss effective strategies to engage kidney transplant recipients in proactive discussions about their post-transplant care. We'll explore the benefits of using the Prospera™ test for ongoing surveillance, ensuring patients understand the importance of early detection and intervention. Enhance your communication skills, empower your patients, and optimize long-term transplant outcomes! 📅Friday, October 4th, 2024 🕒12:00 PM ET | 9:00 AM PT REGISTER HERE: https://ow.ly/Bcnt50TzcyT #Transplant #Natera #Kidney #KidneyCare #PostTransplant
-
Join our upcoming webinar 📊 🩺How to engage your kidney transplant recipients: Being proactive with Prospera™ on their transplant care Hear our Natera clinical nurse coordinator discuss effective strategies to engage kidney transplant recipients in proactive discussions about their post-transplant care. We'll explore the benefits of using the Prospera™ test for ongoing surveillance, ensuring patients understand the importance of early detection and intervention. Enhance your communication skills, empower your patients, and optimize long-term transplant outcomes! 📅Friday, October 4th, 2024 🕒12:00 PM ET | 9:00 AM PT REGISTER HERE: https://ow.ly/HMwp50ThxX3 #Transplant #Natera #Kidney #KidneyCare #PostTransplant
-
Natera Organ Health reposted this
It was an honor to present our abstract regarding differential kinetics of Total and Donor-derived cell-free DNA in BLAD after lung transplant, on behalf of the TIBURON-Lung Study investigators at the 16th Annual Paris international Lung Transplant Conference. Paris is now the City of Love and 🫁‼️ #biomarkers, #lung transplant, #natera
-
📊🧬The recently published SLAM study establishes Prospera Lung as an accurate, noninvasive transplant assessment for Single Lung Transplantation. SLAM is the largest study of commercial dd-cfDNA tests in single lung transplant. Click below to learn more. https://ow.ly/zKG250ToCRo #LungTransplant #Natera
-
NEW ISHLT - International Society for Heart and Lung Transplantation Event 🧬🩸 Two thresholds, one powerful solution | Combining the quantity and fraction of dd-cfDNA in a single blood test to improve the accuracy of noninvasive rejection screening post organ transplantation 📅 Wednesday, September 25, 2024 | 2:00 – 3:00 ET #Natera #ISHLT #ddcfDNA #OrganTransplantation https://ow.ly/In9L50TlchJ
-
NEW ISHLT - International Society for Heart and Lung Transplantation Event 🧬🩸 Two thresholds, one powerful solution | Combining the quantity and fraction of dd-cfDNA in a single blood test to improve the accuracy of noninvasive rejection screening post organ transplantation 📅 Wednesday, September 25, 2024 | 2:00 – 3:00 ET #Natera #ISHLT #ddcfDNA #OrganTransplantation https://ow.ly/fuPg50Tl7P4 Michael Olymbios, MD Natera Suphamai Bunnapradist MD MS UCLA Brent Lampert, DO, The Ohio State University Wexner Medical Center Roopa Rao, MD, Indiana University Health
-
Exciting news in organ donation! A recent JAMA study reveals living kidney donation is safer than ever. This increased safety, attributed to newer surgical techniques, could boost living donation rates. With 90,000 people awaiting kidney transplants in the US, this news offers hope to patients and potential donors alike. While short-term risks have decreased, potential donors should still consider long-term factors. Nevertheless, this study marks a significant advancement in transplant medicine. #OrganDonation #KidneyTransplant #MedicalAdvancement https://ow.ly/j2Sf50TjmPn
Donating a kidney is even safer now than long thought, US study shows
apnews.com